Photobiomodulation therapy is a form of light treatment that uses red and near-infrared wavelengths to trigger biological changes inside cells, primarily by boosting energy production in mitochondria. Previously called low-level laser therapy (LLLT), it involves shining specific wavelengths of light onto tissue to reduce inflammation, promote healing, and relieve pain, all without cutting, heating, or otherwise damaging the body. The science behind it is more grounded than the name might suggest, and the range of conditions it is being studied for has expanded considerably in recent years.
What the Therapy Actually Involves
Photobiomodulation (PBM) uses light in two main wavelength bands: red light, roughly 620 to 700 nanometers, and near-infrared light, roughly 700 to 1,440 nanometers. These wavelengths sit just beyond what we can see with our eyes (in the case of near-infrared) or at the deep-red end of visible light. The light can come from either a laser or an LED device. Both deliver photons to the skin and underlying tissue; they differ mainly in how focused the beam is and how the light is generated, not in the fundamental biology they set off once photons reach their target.1Elsevier. Photobiomodulation CME part I: Overview and mechanism of action
A treatment session looks unremarkable. A clinician or the patient positions a light-emitting device over the treatment area for a set time, usually a few minutes. The light does not feel hot and does not burn. There is no UV radiation involved, so the risks associated with sun exposure or tanning beds do not apply here. The entire premise is that very specific wavelengths of light, at the right dose, nudge cellular machinery in a beneficial direction without any tissue damage.
How Light Changes What Happens Inside a Cell
The core mechanism centers on an enzyme sitting inside mitochondria called cytochrome c oxidase (often abbreviated CCO). This enzyme is a critical piece of the cellular energy chain. It contains metal centers, specifically two heme groups and two copper centers, that help shuttle electrons along the chain that ultimately turns oxygen into water and drives the production of ATP, the molecule cells use as fuel.2PubMed Central. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation
Here is where the light comes in. Under normal conditions, a small molecule called nitric oxide can bind to one of those copper centers and slow the enzyme down, like a hand on the brake. Red and near-infrared photons appear to knock that nitric oxide loose, releasing the brake and allowing the enzyme to run faster. The result is increased oxygen consumption and a bump in ATP production. That freed-up nitric oxide also drifts into the surrounding tissue, where it can dilate blood vessels and improve local blood flow.2PubMed Central. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation
So the first domino is straightforward: light hits a specific enzyme, displaces an inhibitor, and energy production goes up. But that first domino sets off a cascade of secondary effects that explain why PBM has been studied for such a wide range of conditions.
The Downstream Chain Reaction
Once cytochrome c oxidase speeds up, several things happen in quick succession. ATP levels rise, giving cells more energy to carry out repairs and normal functions. There is a brief burst of reactive oxygen species, the same molecules that in excess cause oxidative damage, but in small controlled amounts actually serve as signaling molecules that activate protective pathways. Nitric oxide levels increase locally, improving circulation. And calcium levels inside cells shift, which influences everything from gene expression to how cells communicate with each other.3PubMed Central. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation
Cytochrome c oxidase is not the only molecule absorbing light. Calcium ion channels, possibly activated through light-sensitive proteins called opsins, appear to be a second set of targets. Between these two pathways, PBM activates a surprisingly broad set of cellular responses: cells ramp up their antioxidant defenses, oxidative stress drops, and inflammatory signaling calms down.3PubMed Central. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation
That anti-inflammatory effect is one of the most consistently observed outcomes in PBM research. Inflammation is the body’s alarm system, and it is essential for fighting infection and starting the healing process. But chronic or excessive inflammation drives pain, tissue damage, and a long list of diseases. The ability of PBM to dial back that inflammatory response without suppressing the immune system entirely is a large part of why researchers keep finding new potential applications for it.
Pain and Musculoskeletal Conditions
The area where PBM has the most accumulated clinical evidence is musculoskeletal pain. Both laser-based and LED-based PBM devices have been shown to reduce inflammation, decrease swelling, promote healing, and lower pain across a range of joint and muscle conditions.4PubMed Central. Low-intensity LASER and LED (photobiomodulation therapy) for pain control of the most common musculoskeletal conditions
The list of conditions studied is extensive. Evidence supports pain reduction in osteoarthritis, generalized knee pain, fibromyalgia, temporomandibular joint disorders (TMJ), neck pain, and low back pain. There is also evidence for benefit after total hip replacement surgery.4PubMed Central. Low-intensity LASER and LED (photobiomodulation therapy) for pain control of the most common musculoskeletal conditions
How strong is that evidence? It varies by condition. For osteoarthritis of the knee, for example, there are enough trials that the pattern is fairly convincing. For something like fibromyalgia, the data are thinner and the results more mixed, partly because fibromyalgia itself is a condition with highly variable presentation. Across the board, PBM is typically studied as a complement to other treatments (physical therapy, exercise, medication) rather than as a standalone cure. The practical takeaway for someone with chronic musculoskeletal pain is that PBM is a low-risk option worth discussing with a provider, but it is not likely to replace a full treatment plan on its own.
Wound Healing and Tissue Repair
When tissue is damaged, whether from a surgical incision, a diabetic ulcer, or a sports injury, healing depends on cells migrating to the wound site, dividing, and laying down new structural material. Fibroblasts, the cells that produce collagen and other scaffolding proteins, are central to this process. PBM has been shown to stimulate fibroblast activity, making it a strategy for promoting tissue repair and regeneration.5Frontiers in Bioengineering and Biotechnology. Photobiomodulation in fibroblasts: from light to healing through molecular pathways, omics and artificial intelligence
The mechanism ties back to the same cellular energy boost described above. Fibroblasts with more ATP at their disposal divide faster, migrate more effectively to where they are needed, and produce more of the structural proteins that hold tissue together. The red and near-infrared wavelengths penetrate skin effectively, which makes wounds and surgical sites a natural target for PBM. Some clinicians already use PBM devices postoperatively to speed recovery, and it has been studied in chronic wounds that resist conventional treatment, such as diabetic foot ulcers and pressure sores.
One reason wound healing is an appealing application is that the treatment area is usually accessible and well-defined. You can aim a light device directly at a wound. The penetration depth of red and near-infrared light through skin is enough to reach superficial tissues and even some deeper structures, depending on the wavelength and the power of the device. This practical advantage has made wound care one of the more straightforward applications of PBM to study and deliver clinically.
Brain and Neurological Applications
One of the more surprising frontiers for PBM is the brain. Transcranial photobiomodulation (tPBM) involves shining near-infrared light through the scalp and skull so that photons reach the surface of the brain cortex. The skull attenuates a significant fraction of the light, but enough near-infrared energy gets through to trigger the same mitochondrial mechanisms in neurons that occur in other cell types.6PMC. Photobiomodulation Therapy on Brain: Pioneering an Innovative Approach to Revolutionize Cognitive Dynamics
In brain tissue, those mechanisms translate into a range of effects that are particularly relevant to neurological conditions: stronger neuroprotective signaling, better metabolic efficiency in neurons, reduced neuroinflammation, lower oxidative stress, and even support for the growth of new neurons. Researchers are investigating tPBM for traumatic brain injury, stroke recovery, Alzheimer’s disease, depression, and age-related cognitive decline.6PMC. Photobiomodulation Therapy on Brain: Pioneering an Innovative Approach to Revolutionize Cognitive Dynamics
This is where the excitement and the caution need to coexist. The biological plausibility is real: neurons are packed with mitochondria and are extremely energy-hungry, so anything that improves mitochondrial efficiency should have outsized effects in brain tissue. Early clinical results for conditions like traumatic brain injury have generated genuine interest. But the field is young. Many of the studies are small, use different devices and protocols, and measure different outcomes. For conditions like Alzheimer’s disease, the evidence is mostly preclinical or from small pilot trials, not from the kind of large randomized studies that would settle the question. The science is promising, not proven, for most neurological applications.
Why Dose Matters More Than You Might Think
PBM follows a pattern that is unusual for medical treatments and that catches many people off guard: more is not better. The relationship between dose and effect is biphasic, meaning there is a sweet spot. Too little light energy and nothing happens because the minimum threshold has not been crossed. Increase the dose into the right range and you get stimulation of healing, reduced pain, and the other beneficial effects. But push the dose higher still and the benefits disappear, replaced by inhibition, where the therapy actually suppresses the biological processes it is supposed to help.7PubMed Central. Biphasic Dose Response in Low Level Light Therapy
This biphasic response, sometimes called the Arndt-Schulz curve in PBM literature, has practical consequences. It means that someone using a home LED device who assumes longer sessions or higher-powered lights will give better results could actually be undermining the therapy. It also means that clinical research needs to be careful about dose parameters. Two studies of the same condition can produce contradictory results simply because they used different energy densities. This dosing sensitivity is one reason why the field has sometimes produced confusing or inconsistent clinical data, and why standardizing treatment protocols has been a persistent challenge.
The key parameters that define a PBM dose include the wavelength of the light, the power output of the device, the distance from the tissue, the area being treated, and the duration of exposure. Changing any one of these changes the total energy delivered per square centimeter of tissue, which is the number that determines whether you land in the stimulation zone or overshoot into inhibition. For clinicians and researchers, getting these parameters right is the difference between a treatment that works and one that does nothing or causes setback.
Lasers Versus LEDs
A common question for anyone exploring PBM is whether it matters if the light comes from a laser or an LED. Both deliver photons at the relevant wavelengths. Lasers produce coherent light, meaning the waves are synchronized, and the beam is tightly focused. LEDs produce incoherent light that spreads over a wider area. In clinical settings, both types have demonstrated effectiveness for pain reduction and tissue healing.4PubMed Central. Low-intensity LASER and LED (photobiomodulation therapy) for pain control of the most common musculoskeletal conditions
The practical differences are more about delivery than biology. Lasers can target small, specific areas with high precision and can push more energy into deeper tissues because the beam is concentrated. LED panels cover larger surfaces and are generally simpler and safer for home use since the energy is spread over a broader area, making accidental eye damage or skin burns less likely. For superficial conditions like skin wounds or facial treatments, LEDs work well. For deeper targets like joints or tendons, a laser may deliver energy more efficiently to the right depth. The choice between the two often comes down to the condition being treated, the clinical setting, and cost.
What PBM Does Not Do
A persistent misconception is that PBM is a thermal treatment, that it works by heating tissue the way a heat lamp or infrared sauna does. It does not. The power levels used in PBM are far too low to raise tissue temperature meaningfully. The effects are photochemical, not thermal. Light is absorbed by specific molecules and triggers chemical changes, much the way sunlight triggers vitamin D production in skin, except with different wavelengths and different molecular targets.
Another misunderstanding involves UV light. Some people lump PBM in with other light therapies used in dermatology, like UV phototherapy for psoriasis. These are fundamentally different treatments. UV light carries enough energy to damage DNA and cause sunburn, which is why UV phototherapy requires careful medical supervision. PBM uses wavelengths on the opposite end of the spectrum from UV, in the red and near-infrared range, which do not carry enough energy per photon to break chemical bonds or damage DNA. The safety profile is entirely different.
It is also worth noting what PBM cannot replace. It is not a substitute for surgery when surgery is needed, does not eliminate the need for physical rehabilitation after an injury, and does not cure degenerative diseases. Where it fits best, based on current evidence, is as an adjunct, something that accelerates healing, lowers pain, and reduces inflammation alongside other treatments. The conditions where it has been studied most are ones where inflammation and impaired tissue repair are central problems, which is a large category but not an unlimited one.
Home Devices and the Consumer Market
The growing consumer market for PBM devices, especially red-light panels and wearable near-infrared gadgets, has outpaced the clinical evidence in some areas. Many devices marketed for skin rejuvenation, muscle recovery, or general wellness make broad claims that go well beyond what has been demonstrated in controlled trials. This does not mean the devices are useless, but it does mean the buyer needs to be cautious.
The biphasic dose response is especially relevant here. A device that delivers too little power may not reach the stimulation threshold for any meaningful biological effect, effectively producing expensive red ambient lighting. A device that delivers too much, or is used for excessively long sessions, risks overshooting into the inhibition zone.7PubMed Central. Biphasic Dose Response in Low Level Light Therapy Without knowing the irradiance (power per unit area) of a device and the evidence-based dose for a specific condition, a consumer is guessing. Reputable manufacturers disclose irradiance specifications, but many budget devices do not, or report numbers that have not been independently verified.
Eye protection is another practical concern. Near-infrared light is invisible, so your eyes will not instinctively squint or look away as they would with a bright visible light. Direct exposure from a high-powered near-infrared laser can damage the retina before you realize anything is wrong. LED panels at typical consumer power levels are less risky, but looking directly into any PBM device without appropriate eyewear is inadvisable. Clinical-grade devices almost always come with matched protective goggles, and any home device worth purchasing should as well.